Quercetin and Idebenone Ameliorate Oxidative Stress, Inflammation, DNA damage, and Apoptosis Induced by Titanium Dioxide Nanoparticles in Rat Liver.
Laila M FaddaHanan HagarAzza M MohamedHanaa Mahmoud AliPublished in: Dose-response : a publication of International Hormesis Society (2018)
Titanium dioxide nanoparticles (TiO2-NPs) are extensively used in a wide range of applications; however, many reports have investigated their nanotoxicological effect at the molecular level either in vitro or in vivo systems. The defensive roles of quercetin (Qur) or idebenone (Id) against the hepatotoxicity induced by TiO2-NPs were evaluated in the current study. The results showed that the coadministration of Qur or Id to rats intoxicated with TiO2-NPs markedly ameliorated the elevation in hepatic malondialdehyde (MDA), serum alanine amino-transferase (ALT), glucose, tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), immunoglobin G (IgG), and C-reactive protein (CRP) levels compared to their levels in TiO2-NPs-treated rats. The aforementioned antioxidants also effectively modulated the changes in the levels of serum vascular endothelial growth factor (VEGF), nitric oxide (NO), hepatic DNA breakage, caspase-3, and inhibition of drug metabolizing enzymes (cytochrome P450s; CYP4502E12E1) in rat livers induced by TiO2-NPs toxicity. The histopathological examination of the liver section showed that TiO2-NPs caused severe degeneration of most hepatocytes with an increase in collagen in the portal region, while treatment with the antioxidants in question improved liver architecture. These outcomes supported the use of Qur and Id as protective agents against the hepatotoxicity induced by TiO2-NPs and other hepatotoxic drugs.
Keyphrases
- oxidative stress
- vascular endothelial growth factor
- dna damage
- quantum dots
- visible light
- oxide nanoparticles
- nitric oxide
- drug induced
- induced apoptosis
- ischemia reperfusion injury
- diabetic rats
- rheumatoid arthritis
- cell death
- endothelial cells
- metabolic syndrome
- adverse drug
- cell free
- early onset
- mass spectrometry
- high resolution
- breast cancer cells
- heat shock
- insulin resistance
- cell cycle arrest
- newly diagnosed
- skeletal muscle
- atomic force microscopy